Verici Dx plc (VRCI.L)
Verici Dx plc, together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States.
0.30+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-45.5%
The outlook
Verici Dx plc currently reads as leaning bearish based on below its 50- & 200-day averages, 7% of the way from its 52-week low to high, avg target +867% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range7% of the way from its 52-week low to high
Price targetAvg target +867% vs current price
Market cap
$6.9M
52-wk high
0.99
52-wk low
0.25
50-day avg
0.38
200-day avg
0.58
Trailing P/E
—